Elkathil Tablet (L-Carnitine)

Adult dose

Administer 2-3 g of L-carnitine orally in 2-3 divided doses daily (take orally). The dose may be adjusted according to age and symptoms.

This medication should not be used in patients who have an allergic reaction to this drug or are hypersensitive to soybean oil, soy, peanuts, etc. Caution is required when using this medication in patients with fat metabolism issues, hyperlipidemia, diabetic dyslipidemia, or pancreatitis, especially when used with lipid medications. This medication may cause temporary nausea, vomiting, abdominal pain, diarrhea, and changes in body odor as side effects. Additionally, allergic reactions such as rash, urticaria, and facial swelling may occur, so any unusual symptoms should be promptly discussed with a healthcare provider. Patients with renal impairment may experience muscle weakness symptoms, so caution is necessary. Patients at risk of fat overload should regularly check blood lipid levels and adjust medication doses as needed. When co-administering with other lipid-containing medications, the lipid content in this medication should be taken into account for dose adjustment. Pregnant women or women who may become pregnant should only use this medication when the therapeutic benefits outweigh the potential risks, as its safety is not assured. Breastfeeding women should use this medication cautiously, as it may be transmitted through breast milk.

• temporary area
• vomiting
• abdominal pain
• diarrhea
• body odor
• rash
• hives
• facial swelling
• myasthenia

Drug interactions

This medication should be discussed with a physician or pharmacist when used with injectable lipid agents.

This medication must be stored in a tightly sealed container to prevent exposure to air and moisture. Additionally, it is important to keep the medication at room temperature, preferably between 1°C and 30°C.

Appearance

White, round film-coated tablet

Package unit

90 tablets (10 tablets/PTP packaging x 9)